Hypoxia modulates human eosinophil function

Clinical and Molecular Allergy

Volumn 8, Issue , 2010, Pages

  Nissim Ben Efraim, Alon H ^a   Eliashar, Ron ^b   Levi Schaffer, Francesca ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN BAX; PROTEIN BCL XL; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL VIABILITY; ENZYME PHOSPHORYLATION; EOSINOPHIL; HUMAN; HYPOXIA; INFLAMMATION; MEDIATOR RELEASE;

EID: 77954681747     PISSN: None     EISSN: 14767961     Source Type: Journal    
DOI: 10.1186/1476-7961-8-10     Document Type: Article

References (35)

1. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000, 105:651-663. 10.1067/mai.2000.105712, 10756213.
2. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006, 24:147-174. 10.1146/annurev.immunol.24.021605.090720, 16551246.
3. Puxeddu I, Ribatti D, Crivellato E, Levi-Schaffer F. Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol 2005, 116:531-536. 10.1016/j.jaci.2005.06.007, 16159620.
4. Kay AB, Phipps S, Robinson DS. A role for eosinophils in airway remodelling in asthma. Trends Immunol 2004, 25:477-482. 10.1016/j.it.2004.07.006, 15324740.
5. Eliashar R, Levi-Schaffer F. The role of the eosinophil in nasal diseases. Curr Opin Otolaryngol Head Neck Surg 2005, 13:171-175. 10.1097/01.moo.0000162258.03997.58, 15908816.
6. Saadi S, Wrenshall LE, Platt JL. Regional manifestations and control of the immune system. FASEB J 2002, 16:849-856. 10.1096/fj.01-0690hyp, 12039867.
7. Karhausen J, Haase VH, Colgan SP. Inflammatory hypoxia: role of hypoxia-inducible factor. Cell Cycle 2005, 4:256-258.
8. Nathan C. Immunology: Oxygen and the inflammatory cell. Nature 2003, 422:675-676. 10.1038/422675a, 12700748.
9. Murdoch C, Muthana M, Lewis CE. Hypoxia regulates macrophage functions in inflammation. J Immunol 2005, 175:6257-6263.
10. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438:932-936. 10.1038/nature04478, 16355210.
11. Shih SC, Claffey KP. Hypoxia-mediated regulation of gene expression in mammalian cells. Int J Exp Pathol 1998, 79:347-357. 10.1046/j.1365-2613.1998.00088.x, 10319016.
12. Cramer T, Johnson RS. A novel role for the hypoxia inducible transcription factor HIF-1alpha: critical regulation of inflammatory cell function. Cell Cycle 2003, 2:192-193.
13. Salvato G. Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax 2001, 56:902-906. 10.1136/thorax.56.12.902, 1745985, 11713351.
14. Bateman ND, Shahi A, Feeley KM, Woolford TJ. Vascular endothelial growth factor in nasal polyps: a comparison of asthmatic and non-asthmatic patients. Clin Otolaryngol Allied Sci 2004, 29:677-681. 10.1111/j.1365-2273.2004.00901.x, 15533158.
15. Gosepath J, Brieger J, Lehr HA, Mann WJ. Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal polyps. Am J Rhinol 2005, 19:7-13.
16. Coste A, Brugel L, Maitre B, Boussat S, Papon JF, Wingerstmann L, et al. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur Respir J 2000, 15:367-372. 10.1034/j.1399-3003.2000.15b24.x, 10706506.
17. Horiuchi T, Weller PF. Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol 1997, 17:70-77.
18. Puxeddu I, Alian A, Piliponsky AM, Ribatti D, Panet A, Levi-Schaffer F. Human peripheral blood eosinophils induce angiogenesis. Int J Biochem Cell Biol 2005, 37:628-636. 10.1016/j.biocel.2004.09.001, 15618019.
19. Puxeddu I, Berkman N, Nissim Ben Efraim AH, Davies DE, Ribatti D, Gleich GJ, et al. The role of eosinophil major basic protein in angiogenesis. Allergy 2009, 64:368-374. 10.1111/j.1398-9995.2008.01822.x, 19120069.
20. Puxeddu I, Berkman N, Ribatti D, Bader R, Haitchi HM, Davies DE, et al. Osteopontin is expressed and functional in human eosinophils. Allergy 2010, 65:168-74. 10.1111/j.1398-9995.2009.02148.x, 19804447.
21. Munitz A, Bachelet I, Eliashar R, Moretta A, Moretta L, Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 2006, 107:1996-2003. 10.1182/blood-2005-07-2926, 16254138.
22. Yuan Q, K Frank Austen KF, Friend DS, Matthew Heidtman M, Boyce JA. Human Peripheral Blood Eosinophils Express a Functional c-kit Receptor for Stem Cell Factor that Stimulates Very Late Antigen 4 (VLA-4)-mediated Cell Adhesion to Fibronectin and Vascular Cell Adhesion Molecule 1 (VCAM-1). JEM 1997, 186:2313-323.
23. Gardai SJ, Hoontrakoon R, Goddard CD, Day BJ, Chang LY, Henson PM, et al. Oxidant-mediated mitochondrial injury in eosinophil apoptosis: enhancement by glucocorticoids and inhibition by granulocyte-macrophage colony-stimulating factor. J Immunol 2003, 170:556-566.
24. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascularspecific growth factors and blood vessel formation. Nature 2000, 407:242-48. 10.1038/35025215, 11001067.
25. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001, 107:295-301. 10.1067/mai.2001.111928, 11174196.
26. Faller DV. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol 1999, 26:74-84. 10.1046/j.1440-1681.1999.02992.x, 10027074.
27. Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003, 170:3369-3376.
28. Wong CK, Zhang JP, Lam CW, Ho CY, Hjelm NM. Opposing effects of sodium salicylate and haematopoietic cytokines IL-3, IL-5 and GM-CSF on mitogen-activated protein kinases and apoptosis of EoL-1 cells. Immunol Invest 1999, 28:365-379. 10.3109/08820139909062270, 10574634.
29. Adachi T, Choudhury BK, Stafford S, Sur S, Alam R. The differential role of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions. J Immunol 2000, 165:2198-2204.
30. Okuda K, Sanghera JS, Pelech SL, Kanakura Y, Hallek M, Griffin JD, et al. Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase. Blood 1992, 79:2880-2887.
31. Berra E, Pages G, Pouyssegur J. MAP kinases and hypoxia in the control of VEGF expression. Cancer Metastasis Rev 2000, 19:139-145. 10.1023/A:1026506011458, 11191053.
32. Richard DE, Berra E, Gothie E, Roux D, Pouyssegur J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 1999, 274:32631-32637. 10.1074/jbc.274.46.32631, 10551817.
33. Kato M, Liu MC, Stealey BA, Friedman B, Lichtenstein LM, Permutt S, et al. Production of granulocyte/macrophage colony-stimulating factor in human airways during allergen-induced late-phase reactions in atopic subjects. Lymphokine Cytokine Res 1992, 11:287-292.
34. Woolley KL, Adelroth E, Woolley MJ, Ellis R, Jordana M, O'Byrne PM. Effects of allergen challenge on eosinophils, eosinophil cationic protein, and granulocytemacrophage colony-stimulating factor in mild asthma. Am J Respir Crit Care Med 1995, 151:1915-1924.
35. Yamashita N, Tashimo H, Ishida H, Kaneko F, Nakano J, Kato H, et al. Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF). Cell Immunol 2002, 219:92-97. 10.1016/S0008-8749(02)00565-8, 12576027.